Work

A multicenter single-arm study of induction EC/EP plus camrelizumab followed by maintenance camrelizumab plus apatinib in treatment-naive advanced or metastatic extrapulmonary neuroendocrine carcinoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4176

Authors: Yuhong Dai, Qiao Huang, Yifan Fu, Xianglin Yuan, Yanmei Zou, Mingsheng Zhang, Liang Zhuang, Qiuyun Guo, Zuhua Chen, Liu Huang, Li Sun, Hong Qiu

Institutions: Tongji Hospital, Huazhong University of Science and Technology, Yichang Central People's Hospital

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162496103

Cites:

Cited by:

Related to: